MedTrace Logo

A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions

NCT04862559 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-04-28

No results posted yet for this study

Summary

This is an open label, single-center, prospective, pivotal study in which the investigational device, NovaCross™ micro-catheter, will be tested in up to 15 patients scheduled to undergo CTO-PCI using an anterograde approach.

Conditions

  • Chronic Total Occlusion

Interventions

DEVICE

NovaCross

A device that is intended to asisst interventional cardiologists during catheterization to cross and open coronary chronic total occlusions

Sponsors & Collaborators

  • Nitiloop Ltd.

    lead INDUSTRY

Principal Investigators

  • Chanan Schneider, Mr. · Company Employee

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2017-09-17
Completion
2017-09-17

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04862559 on ClinicalTrials.gov